Trevena, Inc. (TRVN)
OTCMKTS · Delayed Price · Currency is USD
0.0010
0.00 (0.00%)
At close: Aug 17, 2026
Trevena Market Cap
Trevena has a market cap or net worth of $959 as of August 21, 2026. Its market cap has decreased by -99.64% in one year.
Market Cap
959.00
Enterprise Value
n/a
Revenue
546.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since January 31, 2014, Trevena's market cap has decreased from 167.27M to 959.00, a decrease of -100.00%. That is a compound annual growth rate of -61.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 959.00 | -91.66% |
| Dec 31, 2025 | 11.51K | -99.11% |
| Dec 31, 2024 | 1.30M | -88.18% |
| Dec 29, 2023 | 10.96M | -0.67% |
| Dec 30, 2022 | 11.03M | -88.49% |
| Dec 31, 2021 | 95.83M | -71.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DNAPrint Genomics | 1.30K |
| GlobeStar Therapeutics | 1.24K |
| Adhera Therapeutics | 1.16K |
| ContraFect | 1.07K |
| RegeneRx Biopharmaceuticals | 1.06K |
| American Oriental Bioengineering | 949.00 |
| Lyra Therapeutics | 710.00 |
| Pathfinder Cell Therapy | 667.00 |